Skip to content
Disclosery

SymBiosis Capital Partners, LLC

Follow

13F filer, CIK 2006045, BENTONVILLE, AR

SymBiosis Capital Partners, LLC reported $52,769,920 across 6 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002006045-26-000007

Period
2026-03-31
Reported value
$52.8M
Holdings
6
Top 10 weight
100%
New
1
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
WVEnew+750,000$5.44M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VSTMexited-2,000,000-$15.4M
AMPGexited-2,555,000-$13.2M
PGENexited-3,000,000-$12.5M
NUVBexited-1,250,000-$11.2M
AARDexited-476,595-$6.26M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0002006045-26-000007, largest first. % of portfolio is the value over $52,769,920, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: not loaded; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,280,778 shares; 2026Q1: 1,280,778 shares 1,280,778$29.4M55.8%0Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: not loaded; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,600,000 shares; 2026Q1: 2,354,000 shares 2,354,000$13.1M24.76%-246,000Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: not loaded; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 750,000 shares 750,000$5.44M10.3%newTimeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: not loaded; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 6,300,000 shares; 2026Q1: 3,667,585 shares 3,667,585$2.69M5.11%-2,632,415Timeline
CLNNCLENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: not loaded; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 770,495 shares; 2026Q1: 431,094 shares 431,094$2.13M4.03%-339,401Timeline
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: not loaded; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares 150,000$2.4K<0.01%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VSTMVERASTEM INC2,000,000$15.4Mshares
AMPGAMPLITECH GROUP INC2,555,000$13.2Mshares
PGENPRECIGEN INC3,000,000$12.5Mshares
NUVBNUVATION BIO INC1,250,000$11.2Mshares
AARDAARDVARK THERAPEUTICS INC476,595$6.26Mshares
GENERATION BIO COGENERATION BIO CO665,000$3.78Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002006045-26-000007 base2026-05-12acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0002006045-26-000007 Quarter ended 2026-03-312026-05-12acceptance time not in the bulk data set
13F-HR 0002006045-26-000002 Quarter ended 2025-12-312026-02-12acceptance time not in the bulk data set